Actions

Summary tables comparing neoplastic disorders: Difference between revisions

From haematologyetc.co.uk

No edit summary
No edit summary
Line 20: Line 20:
|-
|-
|colspan="1" style = "font-size:90%;" |'''CD5'''
|colspan="1" style = "font-size:90%;" |'''CD5'''
|colspan="1" style = "width: 8%; background:#004466;color:white;font-size:80%"|>80 <span style="color:#004466;font-size:100%">long</span><span style="color:#004466;font-size:100%"> longer</span>
|colspan="1" style = "width: 8%; background:#004466;color:white;font-size:80%"|>80 <span style="color:#004466;>long</span><span style="color:#004466;font-size:100%"> longer</span>
|colspan="1" style = "width: 8%; background:#004466;color:white;font-size:80%"|>80
|colspan="1" style = "width: 8%; background:#004466;color:white;font-size:80%"|>80
|colspan="1" style = "background:#E6FAFF;color:black; font-size:80%"|<5%
|colspan="1" style = "background:#E6FAFF;color:black; font-size:80%"|<5%

Revision as of 19:42, 21 June 2023

Immunophenotype LPD
Marker CLL MCL FL
κ/λ 40:80 wk >80 40:80
FMC7 20:40 wk 40:80 40:80
CD5 >80 long longer >80 <5%
CD10 5-20 5-20 >80 Stg
CD11C 20:40 wk 20:40 wk <5%
CD19 >80 >80 40:80
CD20 >80 >80 >80
CD23 >80 5-20 40:80
CD25 20:40 wk 20:40 wk 5-20 wk
CD38
CD43
CD79a wk
CD103
CD138
CD200

Key to table:


Key to colour code Click for link

Key to expression code Click for link